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Abstract
The study of immune responses of peripheral blood in bone regeneration for
bone formation predicting complications is relevant. Studies were carried out on
patients with the facial skeleton injury before and after stable osteosynthesis of the
mandible in a fixing device for external fixation. Of the 136 patients, 17 people’s
bone tissue regeneration has been slow. Laboratory tests were carried out before
and after the operation. The studies included the study of cellular immunity,
humoral immunity, phagocytosis, acute phase proteins and cytokine status. The
obtained data were processed using variation statistics methods and the modified
theorem of T. Bayes. The study revealed that alternating stages of regeneration of
bone tissue (inflammation, proliferation of osteoblasts, collagenogenesis and ossifi-
cation) are accompanied by changes in the immunological status. A comparative
study of the dynamics of immunological parameters at normal and slow osteogene-
sis had made it possible to establish criteria for delayed consolidation of bone tissue.
Prognostic criteria before the operations include increasing the concentration of
IgM and decreasing the concentration of C-reactive protein, in the early postopera-
tive period-increasing the number of leukocytes, the concentration of tumor necro-
sis factor, IgM, as well as reducing the number of CD45+CD3+-cells, the
complement activity and the amount of lactoferrin.
Keywords: monitoring of osteogenesis, prognostic criteria, nitro blue tetrazolium
test, tumor necrosis factor, IgM, C-reactive protein
1. Introduction
Regulation of bone formation when damaged is regulated by a complex set of
factors, including mechanical conditions for the formation of high-grade regenera-
tion, vascular reactions, the influence of the neuroendocrine system, effects of
metabolites and growth factors [1]. A reflection of the processes becomes dynamic
of blood parameters, among which the most important are the changes in the
immune status.
It is known that the immune system and bone tissue have broad functional and
structural connections. The heterogeneity of cell population included in the
immune system and the variety of regulators produced determine its ambiguous
participation in the regulation of bone tissue regeneration.
Both macrophages and osteoclasts develop from the same progenitor cell of the
monocytic line [2]. Both of these cells have the ability to destroy tissues, which leads
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to the activation of repair processes carried out by cells of mesenchymal origin,
fibroblasts or osteoblasts. From stromal cells expressing the most important regula-
tors of osteoclastogenesis and being a natural microenvironment for normal hema-
topoiesis, osteoblasts develop [3].
Quantitative and qualitative changes in immunocompetent cells are due to
lymphocyte-macrophage regulation of osteogenesis and are reflected regeneration
of the bone-favorable or delayed.
An important role in the regulation of bone tissue regeneration belongs to
immune cells-lymphocytes. In an animal experiment, it was shown that thymec-
tomy leads to a significant delay in osteogenesis after a bone fracture [4]. Different
lymphocyte populations influence the regulation of bone tissue regeneration
ambiguously: when analyzing the cellular composition of the regeneration zone in
difficultly fused fractures, a significant decrease in the number of T cells, the
absence of mast cells and the predominance of fibroblasts and mononuclear cells
was revealed [5]. There are reports that with severe mechanical polytrauma, deep
disturbances of the cellular immunity are observed in the form of inhibition of the
expression of CD2DR+ receptors and a decrease in the absolute number of cells
with CD4+ and CD8+ phenotypes [6]. It was also shown that the activity of NK cells
is significantly reduced among the patients in the fracture zone, as well as in
peripheral blood [7]. A number of authors have found that in animals with a
deficiency of mature T lymphocytes, physiological metabolism in bone tissue is not
disturbed [8]. However, under conditions when there was a need to increase bone
metabolism (in trauma and after surgery), deficiency of T-lymphocyte function led
to the formation of demineralized bone matrix and loss of density of existing bone
tissue [9]. Clinical studies had also confirmed the role of T lymphocytes in the
regulation of bone density. It was revealed that both CD4+ and CD8+ cells can
produce factors that affect osteoclastogenesis [10]. There are a number of studies
that show the inhibitory role of T lymphocytes in relation to the formation of
osteoclasts and resorptive changes in the bone [11]. It is indicated that activated T
lymphocytes can reduce osteoclastogenesis by producing INF-γ. In vitro, the
removal of CD8+ T lymphocytes from a cell culture containing both osteoclast pre-
cursors and bone marrow cells significantly increases the formation of mature
osteoclasts [12]. Some in vivo data indicate the involvement of the prostaglandin
mechanism in this process [13]. In various pathological conditions, the nature of the
influence of T lymphocytes on osteoclastogenesis is determined by both a set of
locally secreted cytokines and the degree of differentiation of T lymphocytes [14].
Bone resorption caused by some cytokines secreted by T lymphocytes is often
accompanied by further increased bone tissue formation, which leads to an increase
in bone metabolism [15]. The direct molecular mechanisms of influence, as well as
the conditions that determine the stimulating or inhibitory role of T lymphocytes in
the regulation of bone tissue regeneration, are under study.
B lymphocytes are also involved in the regulation of bone tissue regeneration. In
the bone marrow, the earliest precursors of B lymphocytes are in close contact with
the endosteal surface of the bone, and the most mature cells of this series are located
in the center of the bone marrow. Such a spatial organization of B lymphopoiesis in
the bone marrow suggests that the cells of the osteoblastic germ located in the
endosteum, as well as stromal cells located in the connective tissue stroma of the
bone marrow, produce factors that influence the early precursors of B lymphocytes.
It has been suggested that molecules like vascular cell adhesion molecules
(VCAMs), expressed on the surface of stromal cells, mediate the binding of lym-
phocyte precursors, predominantly B lymphocytes, since the latter form an essen-
tial part of the entire lymphoid component of the bone marrow. It was also revealed
that this molecule plays an important role in the phenomenon of homing of
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lymphocytes into the bone marrow [16]. These cells and bone tissue molecules, as it
turned out, ultimately realize their effect on B lymphocytes through the transcrip-
tion factor Pax5 (B-cell specific activator). In the absence of this factor, maturation
of B lymphocytes does not occur. In this case, immature pre-B cells can differentiate
into other cells of bone marrow origin, for example, into macrophages, osteoclasts
and other cells [17]. The lack of mature lymphocytes in bone tissue is reliably
associated with an increased volume of trabecular bone tissue [18]. It is interesting
to note that under physiological conditions [19], as well as under the conditions of
ontogenesis [20], the lack of mature B lymphocytes practically does not affect the
cellular balance and metabolism in bone tissue. However, under pathological con-
ditions or external stimuli, the absence of mature B lymphocytes does not allow
bone tissue to adequately respond to changing conditions [21].
An important role in the regulation of bone tissue regeneration belongs to
neutrophils. The impact of a damaging factor on the tissues leads to the develop-
ment of acute inflammation, the main effectors of which are these cells. The out-
come of the process largely depends on the reactivity of neutrophils [22].
Neutrophils, while not playing a key role in the repair phase, at the same time have
an effect on collagenosis and remodeling of the extracellular matrix of bone tissue.
They produce factors that activate fibroblasts and metalloproteinases (collagenases,
gelatinases and stromalysin), which can catabolize all the main products of extra-
cellular matrix and play an important role in remodeling of bone matrix [23]. When
studying the state of non-specific protection among the victims of severe mechan-
ical polytrauma, it was found that regardless of the nature of the traumatic agent,
the degree and severity of the damage, in almost all cases, certain changes in the
immune system were observed. For example, in the first week after an injury, the
polymorphonuclear neutrophil system was functionally inferior [6]. Currently,
researchers are inclined to believe that the complex interactions between individual
cells of the immune system during the entire post-traumatic period have not been
sufficiently studied. However, it is widely known that bone damage, like any other
traumatic effect, leads to an increase in the migratory ability of polymorphonuclear
neutrophils [24]. At the same time, the mechanism, according to which a sharp
decrease in this migratory ability is noted several times throughout the post-
traumatic period, remains unclear [25]. A study of the role of polymorphonuclear
leukocytes by other scientists showed that a decrease in the number of cells led to a
significant decrease in the mechanical strength of the regeneration. This, according
to the authors, was associated with the outflow of neutrophils into the focus of
inflammation (hematoma revascularization), which was accompanied by the
release of a large number of inflammatory mediators (serotonin, bradykinins and
histamine). This process violated the revascularization of the forming bone callus
and led to a decrease in its mechanical strength [26].
When bone tissue is damaged, reactive changes are noted not only in the cellular
but also in the humoral component of the immune system. It was found that
activated lymphocytes responded with a significant reduction in proliferation when
interacting with the main component of the extracellular matrix-collagen both
in vitro and in vivo [27]. It is also interesting to note that bone tissue injury leads to
the production of autoantibodies to oxidized low-density lipoproteins, and the
concentration of these autoantibodies is quite strongly related to the intensity of
post-traumatic osteogenesis [28]. In the framework of the study of immunoregula-
tion of osteogenesis, a violation of the synthesis of immunoglobulins by lympho-
cytes with damage to bone tissue was established [29]. Some authors also obtained
data on a decrease in the synthesis of immunoglobulins class G in severe mechanical
polytrauma [6].
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Lactoferrin is an important regulator of osteocyte activity that increases bone
formation in vivo [30]. Usually, lactoferrin is secreted under the influence of stim-
uli caused by inflammation, as it is contained in neutrophil secretory granules [31].
Lactoferrin affects the synthesis of chemokines, plays an important immunomodu-
latory function to reduce the high concentration of osteolytic cytokines such as
TNF-α and IL-1α [32] and stabilizes binding complexes [33]; therefore, its direct
effects on the activity and development of osteocytes are apparently supplemented
by these intermediary effects [30]. Reliable data have now been obtained, and it
shows that lactoferrin stimulates osteoblastic growth and acts as a powerful factor
in the survival of osteoblasts, preventing cell apoptosis. In addition, lactoferrin
enhances the function of differentiated osteoblasts [34]. The effect of lactoferrin on
the development of osteoclasts was evaluated in mouse’s bone marrow cultures; as a
result, it was found to exceed the response to such strong growth factors as insulin,
amylin, IL-18, adrenomedullin, C-terminal telopeptides and calcitonin [35]. After
local injection of lactoferrin, active bone growth was established, as well as the
fact that it is a powerful factor in osteoblast growth, which can reduce bone
resorption [30]. Lactoferrin acts on preosteoclasts and a large number of mature
cells of this origin; however, it has no effect on bone resorption by isolated mature
osteoclasts [30]. There is also a report on the effects of lactoferrin leading to bone
resorption, which demonstrates that lactoferrin reduces bone function: a mixed
rabbit bone cell culture is resorbed in a manner independent of RANK (receptor
activator of NF-kB)/RANKL (receptor activator of NF-kB ligand)/OPG
(osteoprotegerin) system [36]. Obviously, the identification of the mechanisms by
which lactoferrin acts on bone cells is important due to the revealed possibilities of the
demonstrated effects, and therefore this direction is being actively studied. The puta-
tive lactoferrin receptor is known to have been identified [37]. There is evidence that
lactoferrin acts through a receptor-bound protein related to the low-density lipopro-
tein family (LRP) [38]. Identification of the LRP1 receptor as a functional lactoferrin
receptor in osteoblasts explains the interaction mechanism and makes it possible to
regulate the physiological or pharmacological effects on the bone, as well as the
introduction of vitamins and other necessary substances into the bone tissue [39]. The
same applies to the revealed LRP5 and LRP6 receptors, structurally associated with
LRP1, which are necessary regulators of osteoblast functions [40]. Thus, lactoferrin,
on the one hand, provides bone growth and, on the other hand, can perform the
therapeutic function of a local agent to restore bone integrity after damage.
Integrins for extracellular matrix proteins also take part in the regulation of bone
tissue regeneration. These receptors are a substrate for adhesion, migration and
differentiation of fibroblasts and osteogenic cells [41]. Receptors provide a link
between the cytoskeleton and the extracellular matrix, transmitting information
about stretching and compression of bone tissue through, the cell membrane [42]
and activate certain signaling pathways, affecting gene expression [43]. It was
found that during the recirculation process, when the cells of the immune system
migrate through tissues and interact with one of the main components of the
extracellular matrix (collagen), and integrins act as receptors, the activation signal
is combined with an antigen-recognizing receptor and is able to change the direc-
tion of action of immunocompetent cells [44]. It is known that the metabolism of
bone tissue during damage is provided by numerous cytokines-IL-1 (interleukin),
IL-3, IL-4, IL-6, IL-11, TNF-α (tumor necrosis factor), TNF-β, colony stimulating
factors, leukemia inhibitory factor, INF-γ (interferon), TGF-β (transforming
growth factor) [45, 46]. There is no doubt that the study of blood immune
responses in patients with damage to the bone will assess their relationship with the
passage of bone formation and find the results obtained practical application. Thus,
current is the study of blood immunological reactions during the regeneration of
bone tissue to predict complications osteogenesis.
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2. Material and methods
The study included 136 patients with lesions of the facial skeleton before and
after stable osteosynthesis of the mandible in a fixing device for external fixation.
Limitation of the injury was on average 12.0  3.0 days. Indications for the use of
external fixation devices in damaged bone were complicated by primary and
secondary shifts: mandibular fractures, in 92 persons (67.6%); disjoint fractures, in
20 persons (14.7%); fused fractures, in 21 persons (15.4%); and gunshot defects, in
3 people (2.2%). A study was authorized by the Ethics Committee, guided by the
order of operation, standard operating procedures and international instruments,
which are based on “Declaration of Helsinki of the World Medical Association” and
its subsequent editions, UN documents and of the Council of Europe documents
relating to the rights of the patient, Consolidated Guideline for Good Clinical Prac-
tice and the National Russian Federation Standard “Good Clinical Practice” GOST R
52379-2005 from 01.04.2006. Informed consent to participate in a research project
in accordance with the “Statement of Ethical Control” had been obtained from all
surveyed participants in this test.
The diagnosis is based on clinical and instrumental learning techniques using
X-ray data, orthopantomography and CT. The volume of surgical intervention
determines the nature and localization of lesions. External or intraoral access was
used. The second type of access was a priority, since its implementation in the
postoperative period was excluded orostoma development. The inner edge of the
subsystems was fixed at 1 cm from the skin surface to avoid damaging the soft
tissue. An important moment during the use of external fixation device was to
restore a fractured bone axis creating contact bone fragments across the fracture
surface and compression at the junction of the bone fragments. Some patients have
been diagnosed with osteomyelitis. When the osteomyelitis was detected,
osteosynthesis was done by opening and draining the purulent chamber. Surgical
treatment of purulent focus was conducted by conventional rules.
Permanent rigid fixation of bone fragments and permanent functional damage
to the load of the lower jaw were created to organize the normal course of the
recovery process and a successful fight against purulent infection. These conditions
of bone tissue restoration were achieved by the periodic-every 5–7 days-tension of
weakened rods and displacement of rings of external retainer relative to each other.
When dressing wounds and fistulas, great importance had been attached to
providing constant drainage of purulent separable. Medical dressings are replaced
in a timely and high-quality manner, taking into account the nature and stage of
wound healing, microbial composition of purulent discharge.
An apparatus for external fixation after treatment was taken off when the
following clinical signs of coalescence bone appeared: disappearance of soft tissue
swelling, lack of mobility at the junction of the bone fragments during the clinical
trial on the motility and on the basis of radiographic criteria: identifying fuzziness
of contour ends of the fragments and improving optical densities in the gap region
of bone damage. Terms of use of metal structures averaged 15.0  3.0 days. Long-
term results of treatment patients were followed up to 4 years.
Of the total patients (136 people) based on retrospective analysis of data, a group
with slow regeneration of bone tissue was isolated, because of osteomyelitis pres-
ence. It amounted to 17 people or 12.5% of all patients. Consolidation of bone tissue
in this group was observed after an average 43.0  1.0 postoperative day. The
control group consisted of patients whose postoperative period was uneventful.
Their consolidation of bone tissue occurs on average through 29.0  2.0 days after
the imposition of an external fixation device. It occurred somewhat earlier than in
the treatment with the other ways. Usually, the terms of consolidation of mandibu-
lar fractures make 34.5–39.7 days.
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The main clinical indicators are as follows: the ratio in the group of patients by
gender and by age, the amount of intraoperative blood loss, presence of concomi-
tant pathology of the cardiovascular, respiratory, urinary systems and the gastroin-
testinal tract, and the presence of allergies and operations, which were previously
carried out using steel structures in both groups significantly did not differ. Labo-
ratory studies were performed preoperatively and after 3 and 10 days and 1 and 3
months after its execution. Blood was obtained in the morning fasting from subcla-
vian vein using the phlebotomy method and from the cubital vein or veins on the
back of the hand, to receive physiotherapy.
To assess the lymphocyte population composition, whole blood with K3EDTA
anticoagulant (ethylenediaminetetraacetic acid) was used at a concentration of
1.6 mg/ml (tube S-Monovette® 2.7 ml, Sarstedt, Germany), for determining the
phagocytic activity of the cells-the blood with the anticoagulant heparin Li (lithium
heparin) at a concentration of 16 IU/ml (tube S-Monovette® 7.5 ml, Sarstedt,
Germany). Serum was used for obtaining tubes S-Monovette® 7.5 ml (Sarstedt,
Germany) with polystyrene beads as activators of coagulation.
To evaluate the immune status, a standard set of laboratory tests has been used
complete with modern diagnostic methods [47]. The number of leukocytes was
determined using hematology analyzer Cell-Dyn 1700 (Abbot, USA), reagents and
equipment from the firm Abbott. Differentiation of population composition of leu-
kocytes was carried out in the Romanovsky-Giemsa stained smears. Stab neutrophil
and segmented neutrophil cell ratio was calculated [48]. Lymphocyte subpopulations
were determined by flow cytometry on the device Coulter®Epics®XL (Beckman
Coulter, USA), using a monoclonal antibody produced by Beckman Coulter. Lysis of
erythrocytes was performed by using the sample preparation station Coulter®Q-Prep
(Beckman Coulter, USA) and reagents Immunoprep, manufactured by Beckman
Coulter. Quality control was performed using gauge particles Flow Check. In vitro
activation of T lymphocytes with phytohemagglutinin was performed and evaluated
in the reaction of inhibition of leukocyte migration [49]. The metabolic activity of
neutrophils was evaluated in the reduction reaction of nitro blue tetrazolium peroxide
radicals under the action of cells and evaluated by light microscopy [50]. Spontaneous
and latex-stimulated activity was determined, their ratio was calculated (stimulation
index). The ability of the neutrophils to kill was determined using cytochemical cell
study data. Myeloperoxidase activity was determined by Grantham-Knoll [51], and
the result was expressed by the average cytochemical coefficient of Kaplow [52]. The
level of the lysosomal cationic cytoplasmic proteins was determined by reaction with
bromophenol blue, and the results are also expressed as the average cytochemical
factor [53]. The content of serum immunoglobulin classes A, M and G was deter-
mined by enzyme immunoassay. Lysozyme activity was evaluated by gel-diffusion
test for the ability to lyse cultureM. lysodeikticus [54], and the functional state of the
complement system was adjusted to 50% by assessment of hemolysis of sheep eryth-
rocytes [49]. Contents lactoferrin and cytokines (IL-1α, IL-8, TNF-α, IL-10 and IL-
1ra) were determined using the method of two-site “sandwich” ELISA-variant using
test systems from firms “Protein contour” (St. Petersburg, Russia), “Cytokine” (St.
Petersburg, Russia), “Vector-Best” (Novosibirsk, Russia) and BioSourse International
(USA) on immunoassay equipment Stat Fax (Awareness Technology Inc., USA). The
concentration of C-reactive protein was determined by turbidimetric and ceruloplas-
min - at Ravin [55].
The selection of antibiotic therapy in osteomyelitis was performed based on
bacteriological examination of wound and aspirate purulent contents of the cavity.
The evaluation included a microscopic examination of a Gram stain, inoculation of
culture media production by bioMérieux (France). Identification of microorgan-
isms and determination of their sensitivity to antibiotics were carried out by the
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analyzers Vitek 2-compact and ATB-Expression (bioMérieux, France). Bacteriolog-
ical examination most frequently detected Staphylococcus aureus (92–95% of cases),
among others were Pseudomonas aeruginosa, Burkholderia cepacia, Acinetobacter
baumannii, Enterococcus faecalis and Proteus vulgaris (the proportion of each of them
in the total number of cases was not more than 1%).
Statistical data processing was carried out using the “Microsoft Office Excel
2007” program and “Statistica for Windows v.6.1”. It included an assessment of the
data on the normality of the distribution in the test groups and was based on data on
the mathematical expectation of 0 and the corresponding standard deviation equal
to 1. Kolmogorov–Smirnov test, Lilliefors, Shapiro–Wilk and χ2 were used to test
the hypothesis that the sample has a Gaussian (normal) distribution. To compare
the variance of the studied samples, F-Fisher criterion was used. Statistical hypoth-
esis is considered confirmed with a significance level of p < 0.05. Modified theory
of T. Bayes was used to identify the prediction criteria [56]. Calculation of diagnos-
tic sensitivity, diagnostic specificity and diagnostic information content of immu-
nological tests was performed using the following Eqs. (1)–(3) [57].
Diagnostic sensitivity ¼
TP
TPþ FN
 
 100 (1)
Diagnostic specificity ¼
TN
TN þ FP
 
 100 (2)
Diagnostic informative laboratory test ¼
TP
TPþ FP
 
 100 (3)
where TP is the true-positive results: the number of patients with complications
who were correctly classified using this criterion; FP is the false-positive results: the
number of patients without complications, which have been erroneously attributed
to the number of patients with complications as a result of this test; TN is the true-
negative results: the number of patients without the complications that were cor-
rectly classified with the help of this test; and FN is the false-negative results: the
number of patients with complications who were misclassified using this test.
3. Results and discussion
As a model for studying the dynamics of immunological parameters in normal
and complicated osteogenesis, the study used laboratory parameters in patients
with lesions of the facial skeleton. Injury of facial skeleton, especially with slow
consolidation of bone tissue, leads to disturbances of body functions and generating
esthetic defects. Therefore, the creation of forecasting system complications of
osteogenesis in the recovery of fractures of the lower jaw becomes important. To
address the issue of participation of immunological reactions in the restoration of
bone tissue, first consider the dynamics of the main laboratory parameters during
normal consolidation lesions of the mandible. Before operation values, immunolog-
ical parameters were compared to known literature data [58, 59].
3.1 Features of immune responses of peripheral blood in normal bone
consolidation
Before surgery, along with a slight increase in the relative number of
CD45+CD3+-, CD45+CD19+-cells revealed increased production of IgA and IgM
(Table 1). There was also a decrease in the activity of oxygen-dependent (nitro blue
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Laboratory parameters Normal values Before surgery 3 days 10 days 1 month 3 months
Total number of white blood cells, 109/l 4.0–9.0 6.850.33 6.680.45 7.300.51 7.350.55 7.300.48
Total number of neutrophils, 109/l 2.00–5.80 4.340.26 4.400.27 4.620.43 4.700.30 4.880.35
Ratio stab neutrophil/segmented neutrophils 0.02–0.06 0.030.01 0.020.01 0.020.01 0.030.01 0.030.01
Total number of monocytes, 109/l 0.09–0.60 0.540.05 0.450.05 0.690.05* 0.500.05 0.520.05
Total number of lymphocytes, 109/l 1.2–3.0 1.890.09 1.560.27 2.080.22 2.150.09* 2.100.09
CD45+CD3+-cells, % 46.0–56.0 60.002.00 63.331.67 51.296.36 62.407.17 62.330.88
CD45+CD19+-cells, % 4.0–8.0 9.501.50 9.671.17 9.710.64 9.201.98 7.330.33
Leukocyte migration inhibition test with phytohemagglutinin, % 0–30 8.030.24 23.021.25* 13.501.08* 5.061.03 22.091.11*
Nitro blue tetrazolium test spontaneous, % 10–20 34.059.10 23.674.77 31.506.36 32.409.05 24.009.64
Nitro blue tetrazolium test stimulated, % 50–100 31.004.00 35.565.59 37.135.94 52.204.46* 49.674.17*
Nitro blue tetrazolium test, stimulation index >1.3 1.000.20 1.830.27* 1.520.26 1.730.14* 2.810.56*
Myeloperoxidase activity of neutrophils, average coefficient cytochemical 1.9–2.8 1.910.25 0.700.12* 2.280.33 2.100.08 0.690.09*
Activity cationic proteins neutrophilic granulocytes, average coefficient cytochemical 1.6–1.9 1.350.12 1.220.11 1.270.02 1.360.12 1.220.05
Lactoferrin, ng/ml 700–1500 825.1012.60 501.0912.65* 1250.9018.34* 836.2125.16 500.0312.89*
IgА, g/l 1.38–2.50 2.890.23 2.690.31 2.890.45 3.180.18 2.030.29
IgM, g/l 0.92–2.10 2.270.03 1.410.23* 1.620.24* 1.600.22* 2.100.63
IgG, g/l 8.5–15.8 12.352.05 11.730.58 12.560.77 12.300.57 11.972.56
Lysozyme, mkg/ml 28.6–31.0 16.231.17 20.801.56* 12.252.37 8.021.88* 14.902.04
Total hemolytic complement activity, arbitrary units/ml 40.0–42.0 50.282.06 36.355.00* 45.302.28 48.062.26 36.7113.38
IL-1α, pg/ml 0–50 22.062.04 21.031.54 625.1812.36* 20.141.98 19.251.15
IL-1ra, pg/ml 0–500 35.240.22 40.081.45* 609.6512.54* 81.072.59* 39.663.08
TNF-α, pg/ml 0–50 11.176.23 25.036.17 141.2533.75* 39.502.98* 24.377.02
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Laboratory parameters Normal values Before surgery 3 days 10 days 1 month 3 months
IL-8, pg/ml 0–50 42.883.64 76.033.60* 415.1211.98* 70.472.65* 39.742.99
IL-10, pg/ml <1.0 2.310.08 0.070.02* 0.020.01* 0.090.03* 0.920.04*
Ceruloplasmin, g/l 0.24–0.42 0.530.02 0.400.05* 0.550.10 0.290.04* 0.330.07*
C-reactive protein, mg/l 0–8 11.505.50 7.502.95 30.8413.40 1.400.25* 0.610.02*
*p < 0.05 compared with preoperative levels.
Table 1.
Immunological parameters of peripheral blood in the regeneration of bone tissue.
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tetrazolium test) and oxygen-independent (neutrophil activity cationic proteins)
killing mechanisms, lowering the concentration of serum lysozyme.
Major changes were detected due to the inflammatory reaction induced by
damage to the bone tissue in the mandible fracture, which was evaluated on the
basis of a complex of acute-phase proteins. Prior to surgery, in particular, it was
revealed that there was an increase in the most sensitive C-reactive protein with
increasing concentration of ceruloplasmin and complement activity, indicating the
presence of acute inflammation (Table 1).
On day 10 after surgery, the number of monocytes increased by 27.8% (p < 0.05)
compared to preoperative level, and at 1 month after surgery, the number of
lymphocytes increased by 13.8% (p < 0.05); the composition of population lym-
phocytes did not change (Table 1). It is known that a recognized mitogen for
assessing the activity of T cells is phytohemagglutinin. According to the stress tests
with phytohemagglutinin, a gain in the functional activity of the cells during the
early postoperative period was identified, that is, for 3–10 days after surgery
(Table 1). In the same period, there was a decrease in the concentration of IgM by
37.9% (p <0.05) with the subsequent restoration of its level in the peripheral blood
(Table 1). Postoperatively, increased activity of “early” killing mechanisms was also
observed: an increase in lactoferrin levels by 51.6% (p < 0.05) and the rise of total
production of reactive oxygen species (nitro blue tetrazolium test) on 83.0% (p < 0.05).
From the humoral immunity, a significant decrease in complement activity was
revealed to be 27.7% (p < 0.05), followed by rapid recovery at 10 days. These changes
appear to have been associated with the participation of complement in the elimination
of foreign substance in the development of inflammatory response.
Due to the fact that not only cellular and humoral reactions played an important
role in the regulation of immunological reactions, but also the effect of a number of
low molecular weight peptides (cytokines) was noted, the dynamics of some of
them was studied. In particular, it was found that in the postoperative period there
was an increase in the concentration of IL-1α (p <0.05), an activator of the initial
stages of the immune response (Table 1). This is likely to determine the develop-
ment and course of a large number of immunological reactions in the reduction of
bone tissue. Simultaneously, the increasing concentrations of receptor antagonist
IL-1–IL-1ra were revealed, which limited the development of systemic inflamma-
tory response (Table 1).
Concentrations of IL-1α and IL-1ra were increased to respectively 28.4 times and
17.3 times to the 10th day of observation compared to preoperative values. A similar
trend was also characteristic of TNF-α (p < 0.05), similar to having IL-1
phlogogenic properties. On day 10, there was a significant increase in the level of
another factor inflammation-IL-8-whose concentration in the blood was increased
9.7 times as compared to preoperative values (Table 1). However, during the
activation process, the decreased concentrations of IL-10 were revealed, which is a
factor that inhibits the synthesis of most of the cytokines. Its concentration in the
serum was reduced more than 100 times (p < 0.05). The inflammatory response in
normal bone regeneration had little activity and duration.
It is known that the regeneration of bone tissue composed of several sequentially
successive stages: inflammation, proliferation of osteoblasts, collagenogenesis and
ossification. In this case, additional studies were conducted 3 months after the
operation, at the last stage when the external fixing device was dismantled, repara-
tive regeneration is completed, the bone tissue has formed and the mandible func-
tioned normally. By the time of full functional bone formation, immunological
parameters were within normal limits.
In a number of patients with osteomyelitis (17 people) based on clinical and
radiographic data, delayed regeneration of bone tissue of the lower jaw was
revealed. It occurs 1.5 times later than normal consolidation (p < 0.05).
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3.2 Features of peripheral blood response in slow consolidation of the mandible
In this group of patients, before surgery, differences in immunological parame-
ters from data obtained on the bone consolidation without complicating osteomye-
litis were revealed. The number of monocytes (Table 2) was lower, than in the
group with the slow regeneration of bone tissue by 59.3% (p < 0.05). There was a
significant attenuation of the bactericidal activity of mechanisms: the level of
lactoferrin was reduced 3.5 times (p < 0.05) was only 33.6% compared with the
normal values. The same can be mentioned for complement activity-30.2% of the
lower limit of normal and below 4.2 times (p < 0.05) than in the group with normal
bone regeneration. Increased concentration of 37.4% IgM (p < 0.05) in peripheral
blood also exceeded 49.0% and the normal values (Table 2). There was increased
functional activity of CD45+CD3+-cells and it was more than 3.5 times (p < 0.05)-
differences in the recorded response of leukocyte migration inhibition (Table 2).
Serum lysozyme was reduced by 5.8 times. Interestingly, the concentration of the
receptor antagonist of IL-1ra concentration was lower for IL-1α (Table 2) that was
not observed in patients with normal bone consolidation. IL-8 levels were reduced
by 1.8-fold (p < 0.05) (Table 2) in comparison with patients with the other group.
The postoperative period was characterized by leukocytogenesis activation: leu-
kocytosis was marked with the change in the ratio of group cells to the segmented
cells. On day 3, a reduction in the number of T cells was shown (according to the
dynamics of CD45+CD3+-cells) 40.8% (p < 0.05), confirming previously published
data [60]. Recovery of these cell populations occurred in 10 days (Table 2). Perhaps
this change in the amount of T cells in the early postoperative period resulting,
ultimately, in disruption of bone regeneration, because it is known that both by
generating INF-γ, and through prostaglandin mechanism of these cells involved in
suppressing bone destruction and the formation of osteoclasts. Decrease in the
relative number of B cells (based on dynamics of CD45+CD19+-cells) by 55.6% (p
< 0.05) was observed later, on day 10 (Table 2).
Important changes were noted by the indicators characterizing the phagocytic
activity of neutrophils. Amplification reactions were detected at 3 days after surgery
when the spontaneous and stimulated superoxide radical production by neutro-
phils’ superior control values was in the subgroup of 1.6- to 1.7-fold (p < 0.05). It
can be assumed that the changes in neutrophil phagocyte system in the blood reflect
the processes occurring in bone tissue. Of interest for the study was the dynamics of
the content of lactoferrin at the stages of bone tissue consolidation (Table 2). As
noted earlier, prior to the operation, its level was significantly reduced. Due to the
fact that lactoferrin causes proliferation of osteoblasts and bone growth, it is not
excluded that lowering the level of lactoferrin in the blood is also one of the reasons
for slow regeneration of bone tissue. Later, after the operation, the lactoferrin
content was always significantly lower in patients with delayed bone formation
compared with patients who have bone fusion that took place at the usual time.
Slow bone formation was accompanied by significant increase (72.0%) in IgM
levels (Table 2). The revealed changes were statistically significant differences
between these patients with normal bone tissue regeneration. Inflammatory
response was characterized by pronounced dynamics of slow-reacting acute-phase
proteins. Specifically, on day 3, after surgery, ceruloplasmin concentration was
higher by 1.9-fold (p < 0.05) than in patients with normal bone regeneration. The
functional activity of T cells throughout the observation period was 2.0- to 3.3-fold
higher (p < 0.05) than in patients with normal consolidation, while it exceeds the
normal value of 1.5 times (Table 1). Active cationic proteins and myeloperoxidase
neutrophilic granulocytes were higher than in patients with complication of osteo-
genesis, respectively, by 33.6% (p < 0.05) and 3.1-fold (p < 0.05). The
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Laboratory parameters Normal
values
Before
surgery
3 days 10 days 1 month 3 months
Total number of white blood cells, 109/l 4.0–9.0 7.080.50 9.080.66*,# 8.430.47* 6.130.38 7.500.51
Total number of neutrophils, 109/l 2.00–5.80 4.370.38 6.950.48*,# 5.171.01 3.630.39# 4.760.69
Ratio stab neutrophil/segmented neutrophils 0.02–0.06 0.040.01 0.080.01*,# 0.060.01# 0.040.01 0.020.01
Total number of monocytes, 109/l 0.09–0.60 0.320.07# 0.520.15 0.300.11 0.590.10* 0.580.18
Total number of lymphocytes, 109/l 1.2–3.0 2.090.20 1.400.22* 2.630.55 1.700.10# 1.940.22
CD45+CD3+-cells, % 46.0–56.0 63.773.24 38.503.51*,# 46.473.54* 63.612.98 47.743.64*,#
CD45+CD19+-cells, % 4.0–8.0 7.030.89 9.062.01 4.310.59*,# 5.880.47# 12.710.36*,#
Leukocyte migration inhibition test with phytohemagglutinin, % 0–30 28.455.46# 45.455.07*,# 44.736.98# 42.075.32# 91.0912.34*,#
Nitro blue tetrazolium test spontaneous, % 10–20 41.125.96 37.023.99# 23.076.34* 45.235.87 25.315.34*
Nitro blue tetrazolium test stimulated, % 50–100 31.093.88 60.501.54*,# 38.184.67 68.345.46*,# 39.966.13
Nitro blue tetrazolium test, stimulation index >1.3 0.750.21 1.640.24* 1.650.13* 1.510.22* 1.500.14*,#
Myeloperoxidase activity of neutrophils, average coefficient cytochemical 1.9–2.8 1.880.14 2.190.18# 2.120.15 1.370.19# 0.770.12*
Activity cationic proteins neutrophilic granulocytes, average coefficient
cytochemical
1.6–1.9 1.420.07 1.630.08*,# 1.360.12 1.550.11 1.260.07
Lactoferrin, ng/ml 700–1500 235.1422.63# 451.0917.35*,# 956.8816.44*,# 566.2223.26*,# 355.8414.87*,#
IgА, g/l 1.38–2.50 2.480.41 2.590.19 2.460.15 2.060.21# 2.680.31
IgM, g/l 0.92–2.10 3.120.38# 1.050.19* 2.800.25# 0.780.13*,# 2.860.34
IgG, g/l 8.5–15.8 15.302.36 11.262.20* 14.131.87 6.310.69*,# 14.511.45
Lysozyme, mkg/ml 28.6–31.0 2.780.49# 3.870.56# 14.212.33* 3.870.49# 13.412.17*
Total hemolytic complement activity, arbitrary units/ml 40.0–42.0 12.071.18# 44.932.51* 13.461.49# 44.032.66* 44.072.37*
IL-1α, pg/ml 0–50 30.243.08# 234.0721.46*,# 604.2618.29* 36.412.65# 18.332.14*
IL-1ra, pg/ml 0–500 18.361.17# 100.5113.96*,# 321.6115.96*,# 24.742.96*,# 13.221.74*,#
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Before
surgery
3 days 10 days 1 month 3 months
TNF-α, pg/ml 0–50 22.656.58 62.5011.54*,# 75.129.67*,# 100.339.89*,# 102.6110.24*,#
IL-8, pg/ml 0–50 24.154.78# 90.323.66*,# 180.7414.85*,# 55.416.74*,# 41.658.97*
IL-10, pg/ml <1.0 2.190.07 0.080.02* 0.040.01* 0.040.01* 0.850.06*
Ceruloplasmin, g/l 0.24–0.42 0.500.02 0.750.16# 0.660.08 0.510.12 0.990.09*,#
C-reactive protein, mg/l 0–8 9.090.22 6.011.12* 0.140.03*,# 0.120.03*,# 0.140.04*,#
*p < 0.05 compared with preoperative levels.
#
р < 0.05 compared with uncomplicated osteogenesis.
Table 2.
Immunological parameters of peripheral blood at slowing bone formation.
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concentration of lysozyme in the same period was significantly reduced by 5.4 times
(Table 2). The dynamics of cytokine concentrations also had differences: on day 3
after surgery significantly, namely more than 11-fold (p < 0.05), increased con-
centration of IL-1α, one of the stimulants of osteoclasts (Table 2). However similar
changes were observed in patients with normal bone tissue regeneration. Most
likely, the ratio between the level of IL-1α and IL-1ra after surgery (on day 10)
played an important role in the violation of regeneration, when in patients with
normal bone consolidation it was equal (Table 1), and at late bone consolidation,
the level of IL -1ra was almost two times lower than the concentration of IL-1α
(Table 2 and Figure 1).
After one month, when the regeneration of bone tissue in the other group was
completed, in patients with delayed consolidation, it was in the stage
collagenogenesis. Features of the dynamics of immunological parameters are as
follows: the number of neutrophils and lymphocytes in peripheral blood was
reduced by 23.0% (p < 0.05) and 21.0% (p < 0.05) compared to those of patients
with normal bone regeneration. Inhibition signs of humoral immunity were shown:
IgA level was lower by 35.3% (p < 0.05), the concentration of IgM (Table 2), and
IgG – 2.0 times (p < 0.05) was compared with the results in patients with the
normal regeneration of the bone tissue. There was also a decrease in
myeloperoxidase activity by 34.8% (p <0.05) and lysozyme concentration by 2 times
(p < 0.05) reduced (Table 2). One month after surgery, the receptor level antagonist
of IL-1 was higher concentration of IL-1α (Table 2) and TNF-α content was
increased by 2.5-fold (p < 0.05), while the functional activity of the CD45+CD3+-
cells (Table 2), as already mentioned, was increased by 8.3-fold (p < 0.05).
It is interesting that in circumstances where bone regeneration has been com-
pleted, 3 months after the operation, the factors of immune responses, causing the
growth of bone, are reduced. Thus, the concentration of lactoferrin was reduced by
40.5% (p < 0.05) and the number of T cells by 23.4% (p < 0.05). During this same
period, the factors of immune reactions associated with the destruction of the bone
tissue continue to maintain high concentrations. In particular, TNF-α level was
increased by 4.2-fold (p < 0.05) (Table 2). The functional state of T cells in the
neutrophil migration inhibition of the reaction was increased by 4.1 times (Table 2)
metabolic functional activity of neutrophils to normal.
Based on the study, criteria were developed by predicting delayed bone consol-
idation in the treatment of injuries of the lower jaw (Table 3).
These criteria allow for different stages of treatment (before surgery, for 3 or
10 hours after surgery) to predict the development of delayed consolidation of bone
Figure 1.
The ratio of the concentration of IL-1α to IL-1ra, a logarithmic scale was used to represent the data.
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tissue. For each of the criteria, diagnostic sensitivity, diagnostic specificity and
informative test are calculated, that is the ability to predict the possible develop-
ment of delayed consolidation of bone tissue.
To test the statistical hypotheses were recruited separate independent test sam-
ples of 49 people. It included patients with the same embodiments of bone damage
and with the same kind of surgical treatment as the two major groups of the study.
The criteria developed in this study showed that the coefficient of determination in
this independent test sample was in the range of 84.2–97.5%. The joint use of two or
more prognostic indicators allowed to increase the value of a diagnostic test for
3–4%. This fact gives more opportunities to clinicians in predicting delayed bone
formation.
4. Conclusion
The study revealed that the stages of regeneration of bone tissue (inflammation,
proliferation of osteoblasts, collagenogenesis and ossification) are accompanied by
changes in the immunological status. When delayed consolidation of bone tissue
revealed differences of response of individual parts of the immune system, a com-
parative study of the immunological parameter dynamics at normal and slow oste-
ogenesis is possible to establish criteria for delayed consolidation of bone tissue.
Prognostic criteria to the operations include increasing the concentration of IgM
Prognostic
criteria
Morbidity
osteogenesis
Average for
osteogenesis
The diagnostic
sensitivity of
the test
laboratory
The diagnostic
specificity of
the test
laboratory
Diagnostic
informative
laboratory
test
Before surgery
IgM, g/l ↑ 2.4 0.9–2.3 85.4% 94.6% 87.3%
C-reactive protein,
mg/l
↓ 9.3 9.4–17.0 79.2% 81.2% 83.2%
3 days
Total number of
white blood cells,
109/l
↑ 6.9 4.0–6.8 92.3% 80.1% 93.1%
CD45+CD3+
-cells, %
↓ 45.0 46.0–70.0 90.4% 92.3% 91.7%
Nitro blue
tetrazolium test
spontaneous, %
↑ 33.0 10.0–32.0 91.4% 77.8% 96.3%
Lactoferrin, ng/ml ↓ 499.0 500.0–
1500.0
81.3% 88.4% 86.2%
TNF-α, pg./ml ↑ 51.0 0–50.0 92.0% 90.9% 94.1%
10 days
Total hemolytic
complement
activity, arbitrary
units/ml
↓ 36.0 37.0–54.0 91.5% 93.0% 92.6%
IgM, g/l ↑ 2.7 0.9–2.6 87.7% 88.3% 89.5%
Table 3.
The criteria for predicting delayed consolidation of bone tissue in the treatment of lesions of the mandible.
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and decreasing in concentration of C-reactive protein in the early postoperative
period-increasing the number of leukocytes, the concentration of tumor necrosis
factor, IgM, the production of superoxide anion in nitro blue tetrazolium test, as
well as reducing the number of CD45+CD3+-cells, complement activity and the
content of lactoferrin.
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